Processing Your Payment

Please do not leave this page until complete. This can take a few moments.

Life Sciences Forum

WBJ Central Mass Life Science Forum

Thank you to all of our speakers, sponsors and everyone who joined us for this special forum!

Click Here to view the State's TEAM MA, Leading Future Generations Economic Development Plan.

The Central Mass Advantage

The Life Sciences Industry has seen incredible growth the last decade, and Massachusetts has become a worldwide leader with continued industry growth and expansion underway. While the epicenter of the industry cluster remains in Kendall Square, the state’s strategy calls for the expansion of lab and manufacturing space throughout the state, with the potential for significant growth in Central MA. Worcester, Marlboro and Devens are already well positioned with leading life science companies in their backyard, while other communities in the region are looking to capitalize on the industry’s westward movement. The advantages for companies to expand in Central Massachusetts are significant, including lower cost of land and facilities and access to more affordable housing for employees.

This special forum features keynote speaker, Secretary Yvonne Hao of the Executive Office of Economic Development, along with a panel of industry leaders who will discuss the opportunities and impediments to growth they have experienced in Central MA/MetroWest. We’ll also discuss the effect of industry clusters of research and resources, and how that can help recruit life science companies and provide fertile soil for their growth in Central MA.

WBJ Web Partners

KEYNOTE SPEAKER

  • Yvonne Hao
    Secretary of the Executive Office of Economic Development, State of Massachusetts

Panelists:

  • Annu Jain
    Senior Innovation Director, Cytiva
  • Catherine Bouthillier
    Senior Manager, Healthcare Corporate Partnerships, WPI
  • Maurice Phelan
    President, Sartorius North America
  • Jon Weaver
    President & CEO of Massachusetts Biomedical Initiatives (MBI)
  • Scott Nickerson
    Senior Vice President of Individualized Neoantigen Therapy Manufacturing, Moderna

MODERATOR

  • Meredith Harris
    Executive Director, Marlborough Economic Development Corporation